GeneNews signs agreement with Eli Lilly and Company
Oct 28, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
Companies: Eli Lilly & Co.
(LLY), GeneNews Ltd
(GNWSF)
GeneNews Limited, a Canada-based molecular diagnostics company, has entered into an agreement with Eli Lilly and Company, under which Eli Lilly would have a selective access to research from its osteoarthritis genomic biomarker program. Eli Lilly is a US-based pharmaceutical company.
Deal Type Partnership
Sub-Category Licensing Agreement
Deal Status Announced: 2009-10-27
Deal Participants
Partner 1 (Company) Eli Lilly and Company
Partner 2 (Company) GeneNews Limited
Copyright (C) 2009 Datamonitor Financial Deals Tracker. All rights reserved
News Provided by COMTEX
Companies: Eli Lilly & Co.
(LLY), GeneNews Ltd
(GNWSF)
Related terms: canada, partnership, pharmaceuticals, research
Related Articles
GeneNews Provides Eli Lilly and Company with Access to its Osteoarthritis Biomarker Program - News,
Oct 27, 2009
...CAREER FAIRS COMPANY PROFILES RESEARCH... PROFILES Company Profiles START UPS Companies Events INTELLIGENCE...TO) Provides Eli Lilly and Company (LLY) (JOBS...its Osteoarthritis Biomarker Program 10/27/2009...
Robbins Graphics Upgrades to a ValueJet 1614 Printer
Oct 21, 2009
...ValueJet 1614-64" printing system. Company Supplied -- Graphic Arts Online...brokers, advertising and marketing companies, builders and developers, museums, Eli Lilly, and The Indianapolis Zoo. Company Supplied
GeneNews provides Lilly with access to its osteoarthritis biomarker program - Zibb.com
Oct 27, 2009
...osteoarthritis biomarker program GeneNews...GEN), a company focused on...agreement allowing Eli Lilly and Company (NYSE: LLY...osteoarthritis genomic biomarker program. Terms of...partners." Eli Lilly and Company is developing...
Big banks, big pharma, big problems
Oct 12, 2009
...large pharmaceutical companies carries a social responsibility...between society and drug companies has not been fulfilled...about $6 billion, Eli Lilly $3bn, and GlaxoSmithKline...20 pharmaceutical company has access to about...mountain of the top 20 companies is probably unthinkable...
Companies in this article